Acute Coronary Syndromes (ACS) research hub
4 indexed studies · 3 currently recruiting
- not yet recruitingNA
Evaluation of the Effectiveness of an Interdisciplinary Intervention After Acute Coronary Syndrome on Low-Density Lipoprotein Cholesterol Levels
This study looks at new ways to help people in France who have had a heart attack or similar heart problem. It compares usual care with a new plan that includes extra support from nurses, dietitians, and pharmacists. The goal is to see if this new plan helps lower ‘bad’ cholesterol levels more effectively.
France - recruiting
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
This study is checking on people who previously took part in the IVORY trial. It's looking at whether a low dose of a medicine called IL-2 helped reduce heart problems in people who had a heart attack, by lowering inflammation in their blood vessels.
United Kingdom - ongoing, recruitingPhase III and phase IV (Integrated)
Randomized comparison of short versus 12 months prasugrel plus aspirin in patients with acute coronary syndromes treated with percutaneous coronary intervention and everolimus-eluting stents
This study looks at whether taking two anti-clotting medicines for a shorter time (1 month) is as safe and effective as taking them for 12 months, for people who've had a heart attack or similar heart problem and received a stent.
Denmark - recruitingPHASE2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
This study looks at a new drug, Orticumab, to see if it can reduce inflammation in the heart's arteries after a heart attack. Researchers will compare it to a dummy drug (placebo) over 6 months to see its effects.
United States · Czechia · Hungary